Employees: NN (None)Legal category: 5485Size: NoneCreation date: 2001-03-01 (25 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINGHIN-EN-MELANTOIS (59262), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU TILLEUL : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU TILLEUL is a French company
founded 25 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINGHIN-EN-MELANTOIS (59262),
this company of category PME
shows in 2018 a net income positive of 334 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU TILLEUL (SIREN 434775425)
Indicator
2018
2017
2016
Revenue
N/C
N/C
N/C
Net income
334 160 €
355 388 €
320 299 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2018, SELARL PHARMACIE DU TILLEUL generates positive net income of 334 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2018: 320 k€ -> 334 k€.
Net income (2018)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
334 160 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 70%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2018)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
24.801%
Financial autonomy (2018)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.954%
Asset age ratio (2018)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU TILLEUL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
Debt ratio
28.018
22.948
24.801
Financial autonomy
70.403
70.352
69.954
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
24.82018
2016
2017
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Excellent
In 2018, the debt ratio of SELARL PHARMACIE DU TILLEUL (24.80) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
69.95%2018
2016
2017
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Excellent
In 2018, the financial autonomy of SELARL PHARMACIE DU TILLEUL (70.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 327.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2018)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
327.276
Liquidity indicators evolution SELARL PHARMACIE DU TILLEUL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
Liquidity ratio
395.998
312.679
327.276
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
327.282018
2016
2017
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Excellent
In 2018, the liquidity ratio of SELARL PHARMACIE DU TILLEUL (327.28) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE DU TILLEUL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 177 transactions of similar company sales
in 2018,
the value of SELARL PHARMACIE DU TILLEUL is estimated at
4 207 373 €
(range 3 135 801€ - 6 920 145€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2018
177 transactions
3135k€4207k€6920k€
4 207 373 €Range: 3 135 801€ - 6 920 145€
NAF 5 année 2018
Valuation method used
Net Income Multiple
334 160 €
×
12.6x
=4 207 373 €
Range: 3 135 802€ - 6 920 146€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU TILLEUL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU TILLEUL
What is the revenue of SELARL PHARMACIE DU TILLEUL ?
The revenue of SELARL PHARMACIE DU TILLEUL is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DU TILLEUL profitable?
Yes, SELARL PHARMACIE DU TILLEUL generated a net profit of 334 k€ in 2018.
Where is the headquarters of SELARL PHARMACIE DU TILLEUL ?
The headquarters of SELARL PHARMACIE DU TILLEUL is located in SAINGHIN-EN-MELANTOIS (59262), in the department Nord.
Where to find the tax return of SELARL PHARMACIE DU TILLEUL ?
The tax return of SELARL PHARMACIE DU TILLEUL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU TILLEUL operate?
SELARL PHARMACIE DU TILLEUL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart